N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice
Author:
Affiliation:
1. Division of Nephrology, Department of Medicine; The University of Hong Kong
2. Department of Medicine and Therapeutics, and Li Ka Shing Institute of Health Sciences; The Chinese University of Hong Kong
Publisher
Wiley
Subject
Nephrology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.13000/fullpdf
Reference21 articles.
1. Progression in chronic kidney disease;Eddy;Adv. Chronic Kidney Dis.,2005
2. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy;The GISEN Group;Lancet,1997
3. Diabetic nephropathy: landmark clinical trials and tribulations;Chan;Nephrol. Dial. Transplant.,2016
4. Angiotensin-converting enzyme inhibitors;Brown;Circulation,1998
5. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure;Lenfant;Proc. Natl. Acad. Sci. U. S. A.,1989
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A sub-10-nm, folic acid-conjugated gold nanoparticle as self-therapeutic treatment of tubulointerstitial fibrosis;Proceedings of the National Academy of Sciences;2023-10-09
2. The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis;International Journal of Molecular Sciences;2022-10-31
3. Shenqi Yanshen Formula (SQYSF) protects against chronic kidney disease by modulating gut microbiota;Bioengineered;2022-02-19
4. Investigating the antifibrotic potential of N‐acetyl seryl‐aspartyl‐lysyl‐proline sequence peptides;Clinical and Experimental Pharmacology and Physiology;2021-08-18
5. Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice;Hypertension;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3